Hi all,
I've seen a lot of discussion about gyno here and thought I'd do some research. I have found a short scientific review that compares tamoxifen (Nolva) and anastrozole (Adex). It is titled: THE ROLE OF TAMOXIFEN IN REDUCING BICALUTAMIDE-INDUCED GYNAECOMASTIA AND BREAST PAIN. I have uploaded the article for individual reference.
Bicalutamide is a nonsteroidal antiandrogen devoid of other endocrine activity. Indications for its use are treatment of advanced prostate cancer in combination with luteinising hormone releasing hormone (LHRH) agonist therapy and the prevention of disease flare associated with the use of LHRH agonists. Info from Medical Information Management System (MIMS Online - View: Cosudex 50 mg).
This article is an excellent read. It presents findings from various - relatively recent - studies in a clear and concise manner. I hope this information is integrated in future gyno-related discussions.
Quotes From Article
"These recent studies suggest that bicalutamide-induced gynaecomastia and breast pain might not only be prevented by tamoxifen but, in some patients, also treated."
"Anastrozole did not appear to be effective."
"The optimum dose of tamoxifen used in either the prophylaxis [prophylaxis = the prevention of disease] or treatment of gynaecomastia or breast pain remains to be determined."
"Most studies have used a dose of 20 mg/day as this is the dose licensed for early breast cancer, but daily doses of 10–40 mg have been used with similar results."
Important to Note
This review article compares only 3 studies which have experiment times of approximately 12, 3 and 6 months - I've never heard of a PCT going for longer than 6 months.
I think the development of gyno from the investigated Bicalutamide medication follows the same biological pathways as gyno from AAS use.
Reference
Nuttall MC, Harris JP, Dawkins GP. The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain. BJU Int 2007;99(2):243-4.


Reply With Quote


